<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66014</article-id><article-id pub-id-type="doi">10.7554/eLife.66014</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-145512"><name><surname>Wilmes</surname><given-names>Stephan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4112-710X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220473"><name><surname>Jeffrey</surname><given-names>Polly-Anne</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6476-0402</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145511"><name><surname>Martinez-Fabregas</surname><given-names>Jonathan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5809-065X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146398"><name><surname>Hafer</surname><given-names>Maximillian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0853-2637</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167876"><name><surname>Fyfe</surname><given-names>Paul K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3541-2294</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145515"><name><surname>Pohler</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220474"><name><surname>Gaggero</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233269"><name><surname>Lopez-Garcia</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148159"><name><surname>Lythe</surname><given-names>Grant</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232892"><name><surname>Taylor</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233270"><name><surname>Guerrier</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220475"><name><surname>Launay</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220476"><name><surname>Mitra</surname><given-names>Suman</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225775"><name><surname>Piehler</surname><given-names>Jacob</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2143-2270</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-220478"><name><surname>Molina-Paris</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-72867"><name><surname>Moraga Gonzalez</surname><given-names>Ignacio</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9909-0701</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Division of Cell Signaling and Immunology, School of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Applied Mathematics</institution>, <institution>University of Leeds</institution>, <addr-line><named-content content-type="city">Leeds</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Biology</institution>, <institution>University of Osnabrück</institution>, <addr-line><named-content content-type="city">Osnabrück</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">CANTHER and Institut pour la Recherche sur le Cancer de Lille</institution>, <institution>Université de Lille</institution>, <addr-line><named-content content-type="city">Lille</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">INFINITE - Institute for Translational Research in Inflammation</institution>, <institution>Université de Lille</institution>, <addr-line><named-content content-type="city">Lille</named-content></addr-line>, <country>France</country></aff><aff id="aff6"><institution content-type="dept">Department of Biology/Chemistry</institution>, <institution>Universität Osnabrück</institution>, <addr-line><named-content content-type="city">Osnabrück</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-104913"><name><surname>Graw</surname><given-names>Frederik</given-names></name><role>Reviewing editor</role><aff><institution>Heidelberg University</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>C.MolinaParis@leeds.ac.uk</email> (CM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>imoragagonzalez@dundee.ac.uk</email> (IM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>04</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66014</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>18</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Wilmes et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Wilmes et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66014-v1.pdf"/><abstract><p>Cytokines elicit pleiotropic and non-redundant activities despite strong overlap in their usage of receptors, JAKs and STATs molecules. We use IL-6 and IL-27 to ask how two cytokines activating the same signaling pathway have different biological roles. We found that IL-27 induces more sustained STAT1 phosphorylation than IL-6, with the two cytokines inducing comparable levels of STAT3 phosphorylation. Mathematical and statistical modelling of IL-6 and IL-27 signaling identified STAT3 binding to GP130, and STAT1 binding to IL-27Rα, as the main dynamical processes contributing to sustained pSTAT1 levels by IL-27. Mutation of Tyr613 on IL-27Rα decreased IL-27-induced STAT1 phosphorylation by 80% but had limited effect on STAT3 phosphorylation. Strong receptor/STAT coupling by IL-27 initiated a unique gene expression program, which required sustained STAT1 phosphorylation and IRF1 expression and was enriched in classical Interferon Stimulated Genes. Interestingly, the STAT/receptor coupling exhibited by IL-6/IL-27 was altered in patients with systemic lupus erythematosus (SLE). IL-6/IL-27 induced a more potent STAT1 activation in SLE patients than in healthy controls, which correlated with higher STAT1 expression in these patients. Partial inhibition of JAK activation by sub-saturating doses of Tofacitinib specifically lowered the levels of STAT1 activation by IL-6. Our data show that receptor and STATs concentrations critically contribute to shape cytokine responses and generate functional pleiotropy in health and disease.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Horizon 2020 Framework programme</institution></institution-wrap></funding-source><award-id>714680</award-id><principal-award-recipient><name><surname>Wilmes</surname><given-names>Stephan</given-names></name><name><surname>Martinez-Fabregas</surname><given-names>Jonathan</given-names></name><name><surname>Fyfe</surname><given-names>Paul K</given-names></name><name><surname>Moraga Gonzalez</surname><given-names>Ignacio</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>202323/Z/16/Z</award-id><principal-award-recipient><name><surname>Wilmes</surname><given-names>Stephan</given-names></name><name><surname>Moraga Gonzalez</surname><given-names>Ignacio</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was authorized by the French Competent Authority dealing with Research on Human Biological Samples namely the French Ministry of Research. The Authorization number is ECH 19/04. all patients gave their written informed consent</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Python (version 3.7) codes for the ABC-SMC model selection and parameter inference can be found in the public repository &quot;https://github.com/PollyJeffrey/Cytokine_modelling&quot;, along with the results of the analysis. Phospho-proteomic and proteomic datasets were uploaded to the Proteome Exchange platform with accession numbers PXD024657 and PXD024188 respectively. RNA-seq dataset was uploaded in the GSE database with accession number GSE164479.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wilmes</collab></person-group><year iso-8601-date="2021">2021</year><source>Competitive binding of STATs to receptor phospho-Tyr motifs  accounts for altered cytokine responses in autoimmune disorders</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164479">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE164479</ext-link><comment>NCBI Gene Expression Omnibus, GSE164479</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wilmes</collab></person-group><year iso-8601-date="2021">2021</year><source>Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses in autoimmune disorders</source><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride">http://www.ebi.ac.uk/pride</ext-link><comment>Proteome Exchange, PXD024657</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wilmes</collab></person-group><year iso-8601-date="2021">2021</year><source>Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses in autoimmune disorders</source><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride">http://www.ebi.ac.uk/pride</ext-link><comment>Proteome Exchange, PXD024188</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-66014-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>